57 filings
8-K
PASG
Passage Bio Inc
4 Mar 24
Passage Bio Reports Fourth Quarter and Full-year 2023 Financial Results and Provides Recent Business Highlights
7:02am
8-K
PASG
Passage Bio Inc
29 Feb 24
Other Events
4:06pm
8-K
PASG
Passage Bio Inc
5 Jan 24
Regulation FD Disclosure
4:05pm
8-K
PASG
Passage Bio Inc
29 Dec 23
In the Court of Chancery of the State of Delaware
4:15pm
8-K
PASG
Passage Bio Inc
20 Dec 23
Passage Bio Announces Promising Initial Data from Phase 1/2 Clinical Trial of PBFT02 In FTD-GRN and Updated Strategic Priorities
7:05am
8-K
10u7e4lls15e70d i95
13 Nov 23
Passage Bio Reports Third Quarter 2023 Financial Results and Provides Recent Business Highlights
7:00am
8-K
4l0mh9h
1 Sep 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:10pm
8-K
ksekzvonug43i vx74
7 Aug 23
Passage Bio Reports Second Quarter 2023 Financial Results and Provides Recent Business Highlights
7:15am
8-K
e5v5n6px17e
31 Jul 23
Departure of Directors or Certain Officers
7:00am
8-K
uomc40
20 Jul 23
Departure of Directors or Certain Officers
7:00am
8-K
48fz020qzgpclies2o
26 May 23
Submission of Matters to a Vote of Security Holders
12:00am
8-K
3986845h
11 May 23
Passage Bio Reports First Quarter 2023 Financial Results and Provides Recent Business Highlights
7:09am
8-K
75mpzs3 cy
6 Apr 23
Entry into a Material Definitive Agreement
4:30pm
8-K
twr45lxadbm0 417m7wq
10 Mar 23
Regulation FD Disclosure
4:41pm
8-K
eyg 93rf5
6 Mar 23
Passage Bio Reports Fourth Quarter and Full-Year 2022 Financial Results and Provides Recent Business Highlights
7:01am
8-K
sewdjhlntslzhczs6ne
24 Feb 23
Passage Bio Presents Additional Interim Data from Imagine-1 Study for GM1 Gangliosidosis at 19th Annual WORLDSymposiumâ„¢ 2023
7:00am
8-K
4v5mjmjp3ck51cc8w0
9 Jan 23
Results of Operations and Financial Condition
7:02am
8-K
yxqdb14n 1dfvcbtt3
14 Dec 22
Passage Bio Announces Positive Interim Clinical Data from First Six Patients with GM1 Gangliosidosis in Imagine-1 Study
7:00am
8-K
bxkx8k tq
2 Dec 22
Amendments to Articles of Incorporation or Bylaws
4:14pm
8-K
z81s 4vg8e
10 Nov 22
Passage Bio Reports Third Quarter 2022 Financial Results And Provides Business Updates
7:03am